supp.ai
Discover Supplement-Drug Interactions
Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago
drug:
Enalapril
supplement:
Asymmetric Dimethylarginine
Research Papers that Mention the Interaction
“ Enalapril treatment , but not placebo, reduced plasma von Willebrand factor (p = 0.03) and ADMA levels (p = 0.01) and increased NOx levels (p = 0.01) and the ratio of L-arginine to ADMA (p <0.01).”
Long-term angiotensin-converting enzyme inhibition reduces plasma asymmetric dimethylarginine and improves endothelial nitric oxide bioavailability and coronary microvascular function in patients with syndrome X.“Both enalapril and losartan could ameliorate the endothelial function by reducing the concentration of ADMA.”
Help us improve supp.ai, we'd love to hear your feedback: Submit Feedback